KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cardlytics (CDLX) Non Operating Income (2017 - 2025)

Cardlytics (CDLX) has disclosed Non Operating Income for 9 consecutive years, with -$7.9 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non Operating Income rose 46.16% year-over-year to -$7.9 million, compared with a TTM value of -$1.7 million through Dec 2025, down 896.19%, and an annual FY2025 reading of -$1.7 million, down 31.76% over the prior year.
  • Non Operating Income was -$7.9 million for Q4 2025 at Cardlytics, down from $17000.0 in the prior quarter.
  • Across five years, Non Operating Income topped out at $11.6 million in Q2 2024 and bottomed at -$14.7 million in Q4 2024.
  • Average Non Operating Income over 5 years is -$557894.7, with a median of -$43000.0 recorded in 2021.
  • The sharpest move saw Non Operating Income soared 16174.42% in 2022, then crashed 806.57% in 2024.
  • Year by year, Non Operating Income stood at -$43000.0 in 2021, then skyrocketed by 16174.42% to $6.9 million in 2022, then crashed by 69.82% to $2.1 million in 2023, then plummeted by 806.57% to -$14.7 million in 2024, then soared by 46.16% to -$7.9 million in 2025.
  • Business Quant data shows Non Operating Income for CDLX at -$7.9 million in Q4 2025, $17000.0 in Q3 2025, and $5.4 million in Q2 2025.